PIFU (Patient Initiated Follow Up Appointments)
Information about Patient Initiated Follow Up appointments (PIFU
Board and agenda papers March 2023
Agenda and papers for the QE Gateshead NHS Foundation Trust board of directors meeting on Wednesday 29th March 2023.Type: Board papers
Audience: Patients and visitors
Gender pay gap report 2023
Gender pay gap 2023 report for Gateshead Health NHS Foundation Trust.Topic: Equality diversity and inclusion
Type: Report
Audience: Patients and visitors, Staff
Remote dose adjustment for normal eating course
The Remote DAFNE (Dose Adjustment For Normal Eating) course is a clinical appointment that has been developed in partnership with The Open University.Topic: Diabetes
Type: Patient information leaflets
Audience: Patients and visitors
Equality Delivery System Report 2023
The Equality Delivery System (EDS) has been designed to help NHS organisations to review and improve their performance and support in meeting the Public Sector Equality Duty (PSED). The EDS supports the outcomes of the Workforce Race Equality Standard (WRES) and the Workforce Disability Equality Standard (WDES). Our Self-assessment score across the three domains is […]Topic: Equality diversity and inclusion
Type: Corporate Information
Audience: Patients and visitors
Pioglitazone
This leaflet is designed for people taking Pioglitazone for type 2 diabetes. What does this medication do? Pioglitazone helps your body make better use of the insulin it produces to control yourblood sugar levels. How do I take this medication? This medicine is taken once daily at the same time each day, with or without […]Type: Patient information leaflets
Audience: Patients and visitors
Testing for Glucokinase (GCK) gene variations in pregnancy
It is important to know if mum has glucokinase diabetes in pregnancy, because there are differences in how GCK-MODY is managed, compared to gestational diabetes mellitus. If a parent is affected, the baby has a 50% chance of inheriting the GCK geneTopic: Maternity
Type: Patient information leaflets
Audience: Patients and visitors
Oral GLP-1 Analogues (Semaglutide)
This leaflet is designed for people taking an oral GLP-1 (Semaglutide) for type 2 diabetes. What does this medication do? Semaglutide works in the same way as a hormone produced in the gut by increasing theamount of insulin that the pancreas releases in response to food. This can help with blood glucose levels. How do […]Topic: Diabetes
Type: Patient information leaflets
Audience: Patients and visitors
Metformin
This leaflet is designed for people taking Metformin for type 2 diabetes. What does this medication do? Metformin works to lower blood sugar levels. It does this in several ways. It reduces theamount of sugar released by the liver, it reduces the amount of sugar absorbed by the intestine and it increases the sensitivity of […]Topic: Diabetes
Type: Patient information leaflets
Audience: Patients and visitors
Injectable GLP-1 Analogues (Dulaglutide, Exenatide, Semaglutide, Liraglutide, Lixisenatide)
This leaflet is designed for people taking an injectable GLP-1 for type 2 diabetes. What does this medication do? These drugs work in the same way as a hormone produced in the gut by increasing the amount of insulin that the pancreas releases in response to food.This can help with blood glucose levels. How do […]Topic: Diabetes
Type: Patient information leaflets
Audience: Patients and visitors